Q. Guo

Facilitators, Barriers, and Strategies for Health-system Guidance Implementation: A Protocol for a Critical Interpretive Synthesis

Y. Zhu, X. Chu, Q. Wang, 2020 .

2MO Final OS results and subgroup analysis of savolitinib in patients with MET exon 14 skipping mutations (METex14+) NSCLC

H. Zhang, N. Yang, Yuxiang Chen, 2022, Annals of Oncology.